Search details
1.
The neurons that restore walking after paralysis.
Nature
; 611(7936): 540-547, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36352232
2.
Neuroprosthetic baroreflex controls haemodynamics after spinal cord injury.
Nature
; 590(7845): 308-314, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33505019
3.
Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial.
Lancet
; 403(10442): 2416-2425, 2024 Jun 01.
Article
in English
| MEDLINE | ID: mdl-38763153
4.
Required growth facilitators propel axon regeneration across complete spinal cord injury.
Nature
; 561(7723): 396-400, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30158698
5.
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials.
Lancet Oncol
; 24(7): 783-797, 2023 07.
Article
in English
| MEDLINE | ID: mdl-37414011
6.
Abiraterone acetate and prednisolone with or without enzalutamide for high-risk non-metastatic prostate cancer: a meta-analysis of primary results from two randomised controlled phase 3 trials of the STAMPEDE platform protocol.
Lancet
; 399(10323): 447-460, 2022 01 29.
Article
in English
| MEDLINE | ID: mdl-34953525
7.
Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial.
Lancet Oncol
; 23(5): 650-658, 2022 05.
Article
in English
| MEDLINE | ID: mdl-35421369
8.
Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5-year follow-up results from the STAMPEDE randomised trial (NCT00268476).
Int J Cancer
; 151(3): 422-434, 2022 08 01.
Article
in English
| MEDLINE | ID: mdl-35411939
9.
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.
PLoS Med
; 19(6): e1003998, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35671327
10.
TUXEDO: A phase I/II trial of cetuximab with chemoradiotherapy in muscle-invasive bladder cancer.
BJU Int
; 2022 Jul 31.
Article
in English
| MEDLINE | ID: mdl-35908256
11.
The role of radiotherapy in oligometastatic hormone-sensitive prostate cancer.
Curr Opin Urol
; 32(3): 277-282, 2022 05 01.
Article
in English
| MEDLINE | ID: mdl-35249966
12.
Hypofractionated radiotherapy in locally advanced bladder cancer: an individual patient data meta-analysis of the BC2001 and BCON trials.
Lancet Oncol
; 22(2): 246-255, 2021 02.
Article
in English
| MEDLINE | ID: mdl-33539743
13.
Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial.
Lancet
; 396(10260): 1413-1421, 2020 10 31.
Article
in English
| MEDLINE | ID: mdl-33002429
14.
The Lancet Commission on prostate cancer: planning for the surge in cases.
Lancet
; 403(10437): 1683-1722, 2024 Apr 27.
Article
in English
| MEDLINE | ID: mdl-38583453
15.
Abiraterone for Prostate Cancer Not Previously Treated with Hormone Therapy.
N Engl J Med
; 377(4): 338-351, 2017 07 27.
Article
in English
| MEDLINE | ID: mdl-28578639
16.
ErbB receptor signaling directly controls oligodendrocyte progenitor cell transformation and spontaneous remyelination after spinal cord injury.
Glia
; 67(6): 1036-1046, 2019 06.
Article
in English
| MEDLINE | ID: mdl-30637799
17.
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial.
Lancet
; 392(10162): 2353-2366, 2018 12 01.
Article
in English
| MEDLINE | ID: mdl-30355464
18.
Health-related quality of life around the time of diagnosis in patients with bladder cancer.
BJU Int
; 124(6): 984-991, 2019 12.
Article
in English
| MEDLINE | ID: mdl-31077532
19.
Targeted deep sequencing of urothelial bladder cancers and associated urinary DNA: a 23-gene panel with utility for non-invasive diagnosis and risk stratification.
BJU Int
; 124(3): 532-544, 2019 09.
Article
in English
| MEDLINE | ID: mdl-31077629
20.
Patients choose certainty over burden in bladder cancer surveillance.
World J Urol
; 37(12): 2747-2753, 2019 Dec.
Article
in English
| MEDLINE | ID: mdl-30903352